News Focus
News Focus
icon url

acgood

11/07/12 8:38 PM

#151910 RE: DewDiligence #151901

Alny has not abandoned their pcsk9 program...that was isis. But alny IV lead program is dead IMO...any partner would only want the preclinical subcutaneous version which is helplessly far behind unless a safety concern emerges with the antibodies